Lifestyle
- Regular physical activity
- Weight management
- Stress reduction
- Adequate sleep
Resistin · FIZZ3
Resistin quantifies the level of a hormone involved in glucose metabolism and inflammation.
Reference ranges may vary based on age, sex, and health status.
Resistin is an adipokine primarily secreted by adipose tissue, involved in the regulation of glucose metabolism and insulin sensitivity. It is a cysteine-rich protein that plays a role in inflammatory processes and is associated with obesity and metabolic syndrome. Researchers have observed that resistin levels are elevated in obesity, contributing to insulin resistance and inflammation. Clinically, elevated resistin levels are linked to increased risk of type 2 diabetes, cardiovascular diseases, and certain cancers. Resistin is also implicated in the pathophysiology of obesity-related disorders, serving as a biomarker for metabolic dysfunction. In the context of athletic performance and biohacking, resistin may influence energy metabolism and inflammatory responses, potentially affecting recovery and adaptation to exercise. However, its role in longevity is less clear, with ongoing research needed to elucidate its impact. Caveats include potential confounders such as circadian rhythm variations and fasting status, which can influence resistin levels. Researchers found that resistin levels may vary throughout the day, and fasting conditions are recommended for accurate assessment.
Klinische Bedeutung
Elevated resistin levels indicate increased risk of insulin resistance, type 2 diabetes, and cardiovascular diseases. Low levels are less commonly associated with specific clinical conditions.
Progressively rising resistin levels suggest worsening insulin resistance and increased inflammation. Re-test in 4 weeks if outside optimal range.
Falling resistin levels may indicate improved metabolic health and reduced inflammation.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult with a healthcare provider before making significant lifestyle changes.
Resistin levels may vary; morning fasting samples are recommended.
Testing Frequency
Annually for individuals with metabolic risk factors.
Correlated with
Current research suggests that reference ranges for resistin levels in various populations, particularly in children and adolescents, remain poorly defined, and the optimal targets for therapeutic interventions are still debated. Researchers have not yet established the precise role of resistin in mediating obesity-related inflammation and its interactions with other adipokines. Additionally, clinical questions remain unanswered regarding the long-term implications of resistin levels on cardiovascular disease risk and metabolic syndrome progression in diverse demographics.
4,632
Total Citations
16
Human/RCT
7.3
Avg. Influence
2021
Latest
This review examined the relationship between obesity and cancer risk, highlighting that excess body weight is linked to an increased risk of various cancers. Researchers found multiple biological mechanisms that connect obesity to cancer, including insulin resistance and inflammation.
This study investigated the effects of circadian misalignment on cardiovascular risk factors. Researchers observed that misalignment increased levels of inflammatory markers, including resistin, and elevated blood pressure in healthy adults.
This study aimed to identify potential frailty biomarkers, including resistin, associated with aging and age-related diseases. Researchers proposed a biomarker panel that includes resistin as a candidate for assessing frailty in older adults.
Researchers examined the link between human resistin and metabolic diseases, noting its secretion by macrophages. They found that resistin serves as an inflammatory biomarker and may mediate diabetes and cardiovascular disease.
Researchers investigated the role of adipokines, including resistin, in adipose tissue inflammation associated with obesity. They found that obesity leads to increased levels of pro-inflammatory adipokines, which may contribute to metabolic disorders.
Researchers reviewed the effects of pomegranate on type 2 diabetes, noting that certain components can reduce resistin formation and improve metabolic variables. They highlighted the need for further clinical studies to validate these findings.
Researchers examined the relationship between resistin and metabolic diseases, noting that resistin is produced by macrophages in humans and may serve as a biomarker for inflammation and metabolic disorders.
Tripathi Deeksha, et al. · The FEBS journal · 2020
Researchers summarized the diverse roles of resistin in metabolism and inflammation, noting its involvement in insulin resistance and stress response. They highlighted resistin's potential as a biomarker for evaluating disease status.
Key findings
Researchers reviewed the interactions between adipokines, myokines, and hepatokines, emphasizing their roles in metabolic disorders. They found that pro-inflammatory adipokines, including resistin, are secreted more by overweight individuals, potentially contributing to diseases like type 2 diabetes and cardiovascular diseases.
This review highlighted resistin as an inflammatory biomarker linking obesity to various diseases, including cardiovascular conditions and cancer. Researchers discussed its potential role in mediating metabolic disturbances and its implications for diagnostics.
4
Total Trials
264
Total Enrolled
Istinye University
80
2026
Correlation Between Serum and Salivary Fetuin-A and Resistin Levels
Sercan YUKSEL, MD
80
2025
Change in body mass index at 8 months
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
60
2017
Adipokines Plasma Levels (Adiponectin, Leptin, Resistin) at Week 12
59th Medical Wing
44
2004
Research publications about Resistin over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer